_____ Brought to you by Syft Technologies _____
Developing Non-Invasive Breath Tests for Upper Gastrointestinal Tract Cancers
August 4, 2020
8:00 a.m. PDT,
11:00 a.m. EDT,
16:00 BST, 17:00 CEST
In the early stages, cancers of the upper gastrointestinal tract exhibit symptoms that are identical to benign conditions. Because there is currently no low-cost, non-invasive screening test for general practitioners to utilize with patients presenting these symptoms, many patients with early-stage cancer are not detected early enough, a high proportion are diagnosed only at later stages where mortality rates are high, and intervention is often severe.
Research focused on a breath-based screening test using direct mass spectrometry looks a promising alternative. In this webinar, we will describe:
• Why early detection of gastro-esophageal cancers is so challenging,
• Research utilizing selected ion flow tube mass spectrometry (SIFT-MS) that has potential screening applications, and
• Future external validation work that will utilize thermal desorption-SIFT-MS.
Brought to you by:
- Understand the rationale behind research into breath-based diagnostics for upper gastrointestinal tract cancers
- Learn how the SIFT-MS technique is user friendly and extremely flexible (multiple sample introduction options)
- Understand how large-scale external validation studies are essential to biomarker validation
- Breath researchers
- Clinical research scientists using chromatography and/or mass spectrometry
- Those involved in volatile biomarker discovery
- Analytical chemists in CROs
Vaughan Langford, Ph.D.
Syft Technologies, New Zealand
George Hanna, Ph.D.
Head of Department of Surgery and Cancer,
Imperial College London, UK
C&EN Media Group